Chloe Thompson-Peach

Statistics

Publications

Citations

202

H-Index

Active since

2022

Affiliations

South Australian Health and Medical Research Institute(Current)

Centre for Cancer Biology

South Australia Pathology

The University of Adelaide

University of South Australia

Chloe Thompson-Peach is an author at South Australian Health and Medical Research Institute specializing in molecular oncology, oncology, and oncogenic driver mutations.

ORCID

Publications per year

2022–2024

Publications

Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability

Danièl Thomas, Manhong Wu, Yusuke Nakauchi et al. · Cancer Discovery · 2022 · 60 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia

Alexander C. Lewis, Victoria S. Pope, Melinda N. Tea et al. · Blood · 2022 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +16

Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody

Denis Tvorogov, Chloe Thompson-Peach, Johannes Foßelteder et al. · EMBO Reports · 2022 · 35 citations · Full text

Pharmacy, Oncology, Pathology +17

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia

Mahmoud A. Bassal, Saumya E. Samaraweera, Kelly Lim et al. · Nature Communications · 2022 · 21 citations · Full text

Life Sciences, Genetics, Oncology +15

A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure

Monika Kutyna, Chung Hoow Kok, Yoon Lim et al. · Leukemia · 2022 · 21 citations · Full text

Medicine, Cell Biology, Oncology +14

1–5 of 6